Related Experiment Video
Updated: Aug 31, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Predictors of response to antidepressants general principles and clinical implications
1Massachusetts General Hospital, WACC 812, 15 Parkman Street, Boston, MA 02114, USA. anierenberg@partners.org
Abstract:
What variables will predict who should be treated with antidepressants and who should not? If someone should be treated, what variables will predict which treatment is most likely to work? If patients are treated, what will predict who will respond and who will not? Clinicians have asked these questions ever since researchers established that antidepressants were superior to placebo in the treatment of depression. Innumerable reports claim either biologic or psychosocial predictor variables of response, and every few years yet another review of predictors is published in the literature. This article reviews methodologic issues that have been neglected in the pursuit of predictors to antidepressant response and proposes improved requirements for predictor research that would impact clinical practice.
More Related Videos
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
13:18Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
Published on: April 10, 2026
Related Concept Videos
The Placebo Effect
Factors Affecting Drug Response: Overview
Psychosis: Goals of Pharmacotherapy
Antidepressant Drugs: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: MAOIs and Other Agents